pipette
ESEspañol

Synthesis-aware generative design in trillion-scale chemical spaces for automated drug discovery

S. Seo, Y. Sung, S.-Y. Hwang, M. Kang, J. Lee, S. Bordi, L. Raguz, J. Choi, D. Melnichenko, W. Namkung, S. Lee, J. Lim, B. M. Wanner, J. M. Han, W. Y. Kim

PreprintBold claims, read criticallyClaims a big stepReal-world use

In the authors' words

Autonomous drug discovery via generative molecular design is critically bottlenecked by the production of chemically intractable structures. Multi-trillion-scale make-on-demand libraries guarantee synthetic feasibility, but conventional virtual screening cannot efficiently navigate these vast spaces or address multi-parameter optimization. We introduce Hyper Screening X, a generative AI framework integrating structure-based design with automated synthesis hardware. By encoding deterministic reaction logic in a generative flow network, the framework evaluates only 10 million candidates to navigate an 11-trillion-compound space, jointly optimizing physicochemical properties while ensuring compatibility with automated synthesis. Prospective validation against an SLC1A5 variant with a cryptic interface yielded a 96% synthesis success rate and a 50% functional hit rate, identifying two first-in-class lead compounds. This synthesis-aware strategy advances autonomous, closed-loop drug discovery.

Main resultThe abstract does not state a limitation.

Appeared: Friday, October 9. bioRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.10.01.755933